Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/21194249
Conclusion of this study
This represents the most ambitious attempt, to date, to evaluate the clinical efficacy and safety of curcumin as an anti-inflammatory agent. Significant improvements of both the clinical and biochemical end points were observed for Meriva compared to the control group. This, coupled with an excellent tolerability, suggests that Meriva is worth considering for the long-term complementary management of osteoarthritis.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study